SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-24-003688
Filing Date
2024-01-24
Accepted
2024-01-24 17:11:14
Documents
1
Group Members
GNI USA, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A ef20019625_sc13da.htm SC 13D/A 75135
  Complete submission text file 0001140361-24-003688.txt   76944
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 24557513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023
Business Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023 81-3-6214-3600
GNI Group Ltd. (Filed by) CIK: 0001958461 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A